Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COPD Patients”

2,973 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,973 results

Not applicableStudy completedNCT03312322
What this trial is testing

Effects of Lumbar Transcutaneous Electrical Nerve Stimulation on Exercise Performance in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
ADIR Association 10
Large-scale testing (Phase 3)Study completedNCT00206154
What this trial is testing

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,500
Not applicableStudy completedNCT02069054
What this trial is testing

Airway Inflammation and Remodeling in Asthma and COPD.

Who this might be right for
AsthmaCOPD
Medical University of Warsaw 72
Not applicableStudy completedNCT00662805
What this trial is testing

Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 762
Not applicableUnknownNCT05585060
What this trial is testing

The Changes in End Expiratory Lung Impedence Measured by EIT and End Expiratory Lung Volume Measured by Passive Expiratory in Controlled Mechanical Ventilated Exacerbation COPD Patients

Who this might be right for
COPD
The First Affiliated Hospital of Guangzhou Medical University 10
Not applicableUnknownNCT04180670
What this trial is testing

Prevalence of Urinary Incontinence and Evaluation of Related Factors in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseUrinary Incontinence
Sanko University 50
Not applicableUnknownNCT05042154
What this trial is testing

Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment

Who this might be right for
Prevalence of OSA in Patients Hospitalized With COPD Exacerbation
Atlantic Health System 300
Not applicableNot Yet RecruitingNCT07197229
What this trial is testing

Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental Study at Assiut University

Who this might be right for
COPD
Assiut University 70
Testing effectiveness (Phase 2)Study completedNCT02182674
What this trial is testing

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 66
Not applicableStudy completedNCT01986413
What this trial is testing

Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive Ventilation

Who this might be right for
COPDChronic Hypercapnic Respiratory Failure
Institut für Pneumologie Hagen Ambrock eV 21
Not applicableUnknownNCT04142827
What this trial is testing

The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)

Who this might be right for
Bronchiectasis AdultLung InfectionQuality of Life+3 more
Dr. Giuseppe Fiorentino 160
Early research (Phase 1)UnknownNCT01693146
What this trial is testing

STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia

Who this might be right for
COPDHypercapnia
Medical University Innsbruck 30
Not applicableWithdrawnNCT02340702
What this trial is testing

Chronic Obstructive Pulmonary Disease (COPD) in Patients Hospitalized for Acute Decompensated Heart Failure.

Who this might be right for
Disease
Mayo Clinic
Not applicableUnknownNCT03131622
What this trial is testing

Impact of Ibis on Patients With Advanced COPD

Who this might be right for
COPD
Senscio Systems 240
Large-scale testing (Phase 3)Study completedNCT02796677
What this trial is testing

AMPLIFY - D6571C00001 Duaklir USA Phase III Study

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,595
Not applicableStudy completedNCT03077152
What this trial is testing

Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAcute Exacerbation of COPD
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital 138
Not applicableNot Yet RecruitingNCT07305649
What this trial is testing

The Effectiveness of an Innovative Inhalation Training Device in Improving Medication Accuracy, Dyspnea, and Quality of Life in Elderly Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Taipei Veterans General Hospital, Taiwan 82
Not applicableStudy completedNCT06477328
What this trial is testing

Evaluating Chronic Obstructive Pulmonary Disease (COPD) Patients' Treatment Compliance and Quality of Life Via Telemedicine

Who this might be right for
TelehealthCopd
Ankara Etlik City Hospital 74
Not applicableStudy completedNCT01381471
What this trial is testing

Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 11,060
Large-scale testing (Phase 3)Study completedNCT01471171
What this trial is testing

Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 112
Load More Results